Back to Top

Patient Access Network Foundation and CLL Society Announce New Alliance to Provide Support for People Living With Chronic Lymphocytic Leukemia

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

Phone: 202-661-8074

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (September 19, 2016) - The Patient Access Network (PAN) Foundation and the Chronic Lymphocytic Leukemia (CLL) Society today announced they are launching a new alliance to offer a broad range of support for people living with chronic lymphocytic leukemia. Working together, the PAN Foundation and the CLL Society will ensure that people living with chronic lymphocytic leukemia have access to helpful resources and both patient and financial support services, providing them with the holistic support to best manage their disease.

“We’re proud to help patients manage and overcome the financial pressures associated with illnesses like chronic lymphocytic leukemia,” said PAN President and CEO Dan Klein. “We are pleased to partner with the CLL Society to link patients with more comprehensive peer to peer support, including trustworthy disease information, patient-run support groups, clinical trial information and more.”

According to the National Institutes of Health, it is estimated that 18,960 new cases of CLL will be diagnosed in 2016.

“We are pleased to work with PAN and provide this new level of support for our patients and their caregivers,” said CLL Society volunteer Medical Director, Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd. “Receiving a CLL diagnosis and managing the disease can be draining and stressful. Working in partnership with PAN, we can help alleviate some of the financial pressures our patients are facing, allowing them to focus on their health.”

Patients who qualify for the PAN Foundation’s CLL program are eligible to receive up to $11,000 per year in financial assistance. Eligible patients must be getting treatment for CLL; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by Medicare and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided nearly $2.4 billion in financial assistance to more than 605,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

About CLL Society:

The CLL Society Inc. is a patient–centric, physician–curated nonprofit focused on patient education and patient support. Dedicated to addressing the unmet needs of the CLL and related blood cancer communities, it explains the rapidly changing therapeutic landscape and the importance of clinical trials, supports and builds patient networks, and educates providers and patients alike. To learn more, visit cllsociety.org.